most valuable crypto coins People also ask

Zhu Xiaohong, the former party secretary of Guizhou Aerospace Hospital, was decided to be arrested. According to the news of "Guizhou Procuratorate" WeChat WeChat official account, the case of Zhu Xiaohong, the former party secretary of Guizhou Aerospace Hospital (director level), was investigated by Zunyi City Supervision Committee and transferred to the procuratorate for review and prosecution. Under the jurisdiction designated by Zunyi Municipal People's Procuratorate, Fenggang County People's Procuratorate will review and prosecute. A few days ago, the Fenggang County People's Procuratorate made an arrest decision on Zhu Xiaohong on suspicion of accepting bribes. The case is being further processed.European stocks opened slightly lower, with the Stoxx 50 index in Europe down 0.1%, DAX index in Germany up 0.2%, FTSE 100 index in Britain down 0.1% and CAC 40 index in France down 0.1%.Ge Yu, former assistant general manager of China Xinbao Shandong Branch, was examined and investigated. The website of the State Supervision Committee of the Central Commission for Discipline Inspection reported on December 13th that according to the news of the Discipline Inspection and Supervision Team of the State Supervision Committee of the Central Commission for Discipline Inspection in China Export Credit Insurance Company and the Supervision Committee of Liaoning Provincial Commission for Discipline Inspection, Ge Yu, former member of the Party Committee and assistant general manager of Shandong Branch of China Export Credit Insurance Company, was suspected of serious violation of discipline and law. At present, he is being examined by the Discipline Inspection and Supervision Team of the State Supervision Committee of the Central Commission for Discipline Inspection in China Export Credit Insurance Company and supervised by the Supervision Committee of Dandong City, Liaoning Province.

Goldman Sachs lowered the UK's GDP growth forecast for 2024 from the previous 1.2% to 1.0%.Stock index futures continued to fall, and the main contract of SSE 50 Stock Index Futures (IH) fell by 2.00% in the day, and now it is reported at 2,653.6 points. The main contract of CSI 500 stock index futures (IC) fell by 2.00% in the day and is now reported at 5976.8 points.AI glasses ushered in the limelight, and Google reached a cooperation with domestic manufacturers. According to the news, on December 13, at the Android XR conference, Google reached a strategic cooperation with domestic consumer-grade AR glasses manufacturer XREAL to jointly build the Android XR ecosystem. According to media reports, OPPO, vivo, Huawei, Tencent and ByteDance are all evaluating the AI glasses project. In addition, a number of listed companies said on the investor question and answer platform that they have corresponding technology or product reserves in AI glasses. Huaxin Securities Research Report pointed out that AI glasses have become a new outlet in the smart wear market, or lead the next generation of terminal revolution. AI glasses not only have the effect of virtual vision enhancement, but also realize real-time analysis of user behavior and environment by integrating artificial intelligence algorithms, providing more accurate and personalized services. AI glasses also improve comfort and prolong wearing time in design and portability. At the same time, it provides a more natural and convenient interactive experience innovation through various sensing technologies. With the gradual reduction of costs, AI glasses are expected to be further widely used. According to the report of Wellsenn XR, it is estimated that after 2030, the AI+AR smart glasses industry will enter a period of rapid development; By 2035, AI+AR smart glasses will eventually replace traditional smart glasses, and the global sales of AI+AR smart glasses will reach 1.4 billion units, which is equivalent to the size of smart phones and will become the next generation general computing platform and terminal. (Securities Times)

On the 13th, SSE 50 index futures fell by 2.58%, and the latest main contract positions changed as follows. According to the exchange data, as of December 13th, SSE 50 index futures closed at 2,412, up or down by -2.58%, with a turnover of 53,000 lots. The position data showed that the top 20 seats were clear, and the difference position was 7,398 lots. The total number of contracts of SSE 50 index futures was 91,500 lots, an increase of 25,700 lots over the previous day. The first 20 seats in the contract held 88,200 lots, an increase of 2,257 lots over the previous day. The short positions in the top 20 seats of the contract were 113,700 lots, an increase of 1,701 lots over the previous day. (Sina Futures)Anhui procuratorate prosecuted Huawei Yu, the former deputy general manager of Anhui Investment Group Holding Co., Ltd., for allegedly accepting bribes. According to the highest inspection news, a few days ago, Huawei Yu, the former party member and deputy general manager of Anhui Investment Group Holding Co., Ltd., was suspected of accepting bribes, and the Huainan Municipal People's Procuratorate filed a public prosecution with the Huainan Intermediate People's Court according to law after the jurisdiction designated by the Anhui Provincial People's Procuratorate. The case is being further processed. At the stage of examination and prosecution, the procuratorial organ informed the defendant Huawei Yu of his litigation rights according to law, interrogated the defendant according to law and listened to the opinions of defenders. The People's Procuratorate of Huainan City charged that the defendant Huawei Yu, as a national staff member, used the convenience of his position and the convenience of his authority or position to seek benefits for others through the actions of other national staff members, and illegally accepted other people's property alone or in collusion with others. The amount was extremely huge, so he should be investigated for criminal responsibility for accepting bribes according to law.Hengrui Pharma: SHR-2173 injection was approved for clinical trial. Hengrui Pharma announced that its subsidiary, Guangdong Hengrui Pharma Co., Ltd., received the Notice of Approval for Clinical Trial of SHR-2173 injection approved and issued by National Medical Products Administration, and agreed to carry out clinical trial. The indication is lupus nephritis. SHR-2173 injection is a therapeutic biological product independently developed by the company, and the research and development expenses have been invested about 45.03 million yuan. The period from research and development to listing of drugs is long, there are many links, and there are uncertain factors. The company will actively promote research and development projects and fulfill its information disclosure obligations.